[Close]  
Pharmaceutical market research logo; 24-years of Excellence in Market Research since 1988 roundel.


>

Cardiac Rhythm Management Devices: World Market Outlook 2011-2021

Image for Cardiac Rhythm Management Devices: World Market Outlook 2011-2021

Table of Contents

Market Study
Published: December 2011
Pages: 145
Tables: For full details, please email deborahf@cmsinfo.com
From: GBP 1699.00  Buy Now!
Research from: Visiongain
Sector: Indication Areas

How will the cardiac rhythm management devices market perform from 2011? Our new report shows you potential sales and trends to 2021, discussing opportunities and prospects.

Discover sales for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation market at segment and national levels. Our report gives you business research, analysis and data.

See sales predictions and discussions for implantable cardioverter defibrillator devices, pacemakers, cardiac resynchronisation therapy devices and cardiac ablation. Discover opportunities in these markets. Find data you need in our report.
Discover the activities shaping the development of cardiac rhythm management devices market. Through our research and analysis we aim to save you time and help in your decisions.

The market will change with the launch of new products such as devices suitable for use with MRI and biological pacemakers. Find R&D trends and commercial opportunities there.

Assess companies such as Medtronic, Boston Scientific and St. Jude Medical.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Detailed analysis of the global Cardiac Rhythm Management Devices Market

Cardiac Rhythm Management Devices: World Market Outlook 2011-2021 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses, opinions from our survey and a review of companies. Discover over 100 tables and charts and two research interviews (shown in the accompanying lists).

Why you should buy Cardiac Rhythm Management Devices: World Market Outlook 2011-2021

In this report, you will receive the following benefits in particular:
You will receive our assessment of the current market for cardiac rhythm management devices, with respect to the leading segments, products, companies and national markets
You will discover sales trends for the overall cardiac rhythm management devices market from 2011 to 2021 - seeing where commercial growth will occur
You will discover sales trends for the main segments - implantable cardioverter defibrillator, pacemaker, cardiac resynchronisation therapy and cardiac ablation - from 2011 to 2021, with detailed discussions of market potential
You will receive sales forecasts for leading geographical markets (US, Japan, Germany, France, Italy, Spain, UK, China and India), with informed discussion
You will assess leading manufacturers in the cardiac rhythm management devices market
You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the cardiac rhythm management devices market from 2011 onwards
You will be able to investigate competition and opportunities influencing the cardiac rhythm management devices market from 2011 onwards
You will see what will stimulate and restrain the market from 2011
You will discover the unmet needs in the market, driving the growth from 2011 onwards
You will view expert opinion from our survey, including full interview transcripts.

Companies Listed

3M pharmaceuticals
Abbott Laboratories
Ablation Frontiers
ARCO
Astra Zeneca
AtriCure
ATS Medical
Aventis
Biosense Webster
BioTronik
Boston Scientific
Bristol-Myers Squibb
C.R Bard
C.R Bard Electrophysiology
Cameron Health
CardioFocus
Center for Devices and Radiological Health (CDRH)
CryoCath Technologies
CryoCor
Endosense
European Heart Rhythm Association (EHRA)
FDA's MedWatch
Food and Drug Administration (FDA)
Global Harmonization Task Force
Guidant Corporation
Hansen Medical
Impulse Dynamics
InnerPulse
Japanese Ministry of Health, Labour and Welfare (MHLW)
John Hopkins University Medical School
Johnson & Johnson
Karolinska Institute
MedicalCV
Medico
MediVed
Medtronic
MHRA (Medicines and Healthcare Products Regulatory Agency)
New York Heart Association
Odem Medical
Pfizer
ProRhythm
Rainbow Medical
Shree Pacetronix
Siemens Healthcare
Sinai Hospital, Baltimore
Sorin Group
St. Jude Medical
Stony Brook University
Transurgical
UC Davis
University of Bologna
University of Missouri
US Bankruptcy Court for the District of Delaware
World Society of Arrhythmias
Wyeth
Zoll Medical Corporation 

Top of Page